A randomized trial of adoptive immunotherapy with tumor-infiltrating lymphocytes and interleukin-2 versus standard therapy in the postoperative treatment of resected nonsmall cell lung cancer
Data up to Jan 2025
Total Citations Per Year
Abstract
References (22)
Use of Tumor-Infiltrating Lymphocytes and Interleukin-2 in the Immunotherapy of Patients with Metastatic Melanoma
1988 • 2,196 citations
A New Approach to the Adoptive Immunotherapy of Cancer with Tumor-Infiltrating Lymphocytes
1986 • 1,787 citations
A New International Staging System for Lung Cancer
1986 • 1,652 citations
A Randomized Trial Comparing Preoperative Chemotherapy Plus Surgery with Surgery Alone in Patients with Non-Small-Cell Lung Cancer
1994 • 1,244 citations
A Randomized Trial of Induction Chemotherapy plus High-Dose Radiation versus Radiation Alone in Stage III Non-Small-Cell Lung Cancer
1990 • 1,163 citations
Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: Preliminary Results of a Phase III Trial in Regionally Advanced, Unresectable Non-Small-Cell Lung Cancer
1995 • 721 citations
Karnofsky Memorial Lecture. The immunotherapy and gene therapy of cancer.
1992 • 394 citations
Direct demonstration of the clonogenic potential of every human peripheral blood T cell. Clonal analysis of HLA-DR expression and cytolytic activity.
1983 • 351 citations
TUMOUR-INFILTRATING LYMPHOCYTES AND INTERLEUKIN-2 IN TREATMENT OF ADVANCED CANCER
1989 • 337 citations
Use of adoptive transfer of tumor-infiltrating lymphocytes alone or in combination with cisplatin-containing chemotherapy in patients with epithelial ovarian cancer.
1991 • 168 citations
Adoptive immunotherapy with tumor-infiltrating lymphocytes and interleukin-2 in patients with metastatic malignant melanoma and renal cell carcinoma: a pilot study.
1995 • 124 citations
Chest wall involvement by lung cancer: Computed tomographic detection and results of operation
1991 • 120 citations
Continuous interleukin-2 and tumor-infiltrating lymphocytes as treatment of advanced melanoma. A national biotherapy study group trial
1991 • 119 citations
Synergistic antitumor activity of tumor-infiltrating lymphocytes, interleukin 2, and local tumor irradiation. Studies on the mechanism of action.
1990 • 118 citations
Extended continuous infusion low-dose recombinant interleukin-2 in advanced cancer: prolonged immunomodulation without significant toxicity.
1991 • 101 citations
Prediction of Postoperative Clinical Course by Autologous Tumor-Killing Activity in Lung Cancer Patients
1990 • 63 citations
Interleukin-2 and Interferon-α in the Treatment of Patients with Advanced Non-Small-Cell Lung Cancer
1992 • 57 citations
Adjuvant immunotherapy with interleukin 2 and lymphokine-activated killer cells after noncurative resection of primary lung cancer
1995 • 44 citations
Isolation and In vitro expansion of lymphocytes infiltrating non-small cell lung carcinoma: Functional and molecular characterisation for their use in adoptive immunotherapy
1994 • 38 citations
Effect of radiologic stage III substage on nonsurgical therapy of non-small cell lung cancer
1993 • 25 citations
A phase I trial of repeated tumour-infiltrating lymphocyte (TIL) infusion in metastatic melanoma
1995 • 22 citations
Immunotherapy with the use of tumor-infiltrating lymphocytes and interleukin-2 as adjuvant treatment in stage III non-small-cell lung cancer: A pilot study
1995 • 18 citations